New Key Statistics Module, Z-Score and F-Score
OTCPK:ZLSCF Key Ratios
| Market Cap $ M | 47.82 |
| Enterprise Value $ M | 53.14 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 4.50 |
| Price/Sales | 128.57 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | -0.43 |
| Beneish M-Score | -3.84 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -1.78 |
| EV-to-EBITDA | -1.92 |
| PEG | -- |
| Shares Outstanding M | 74.36 |
| Net Margin (%) | -8,086.95 |
| Operating Margin % | -3,700.00 |
| Pre-tax Margin (%) | -9,379.20 |
| Quick Ratio | 0.11 |
| Current Ratio | 0.24 |
| ROA % (ttm) | -82.53 |
| ROE % (ttm) | -151.88 |
| ROIC % (ttm) | -33.52 |
| Dividend Yield % | -- |
| Altman Z-Score | -8.60 |
ZLSCF Number of Guru Trades
ZLSCF Volume of Guru Trades
Gurus Latest Trades with OTCPK:ZLSCF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:ZLSCF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
ZYUS Life Sciences Corp Insider Transactions
No Available Data
News about OTCPK:ZLSCF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers